A New Vaccine for Feline Calicivirus
Author Information
Author(s): Yang Yupeng, Liu Zhe, Chen Mengru, Feng Kexin, Qi Ruibin, Kang Hongtao, Jiang Qian, Qu Liandong, Liu Jiasen
Primary Institution: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China
Hypothesis
Can a virus-like particle (VLP) vaccine effectively protect against both genotypes of feline calicivirus?
Conclusion
The DL39-VLPs vaccine is safe and provides significant protection against feline calicivirus infection.
Supporting Evidence
- Cats immunized with DL39-VLPs showed no significant clinical symptoms after exposure to the virus.
- Neutralization titers against GI strains ranged from 1:151 to 1:538.
- Neutralization titers against GII strains ranged from 1:65 to 1:113.
Takeaway
Researchers created a new vaccine that helps protect cats from a common virus that makes them sick.
Methodology
Cats were immunized with a 50 μg dose of DL39-VLPs and their immune response was evaluated through neutralization tests and challenge trials.
Limitations
The vaccine did not prevent virus excretion in vaccinated cats.
Participant Demographics
15 Chinese field cats, each 2 months old and negative for FCV antibodies.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website